Oral Hypoglycemic Agents
Full Form of OHA
What is OHA?
Oral Hypoglycemic Agents (OHA) are a class of medications administered by mouth to lower blood glucose levels in individuals with type 2 diabetes mellitus. Unlike insulin, which is injected, OHA work through various mechanisms such as increasing insulin secretion, improving insulin sensitivity, reducing hepatic glucose production, or slowing carbohydrate absorption. In India, where diabetes prevalence is exceptionally high, OHA form the cornerstone of pharmacological management for millions of patients. They are prescribed in outpatient clinics, hospital wards, and primary health centers, and are widely discussed in patient education programs. Common OHA classes include biguanides (e.g., metformin), sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, and thiazolidinediones. The choice of OHA depends on factors like glycemic targets, comorbidities, cost, and side-effect profiles. For Indian medical students and professionals, OHA are a key topic in pharmacology and endocrinology. They frequently appear in exams such as NEET PG, AIIMS, and GPAT, where questions cover classification, mechanisms, adverse effects, and drug interactions. Understanding OHA is essential for effective diabetes care in the Indian healthcare system.
OHA का फुल फॉर्म
मौखिक हाइपोग्लाइसेमिक एजेंट
Example
The doctor prescribed a combination of metformin and another OHA to achieve better glycemic control in the patient with newly diagnosed type 2 diabetes.